Literature DB >> 8300000

Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis.

I Emerit1.   

Abstract

Superoxide radicals may induce genotoxic effects by indirect action mechanisms, implicating the formation of more long-lived, secondary clastogenic material called chromosome breakage factors or clastogenic factors (CF). CF are produced via the intermediacy of superoxide, and stimulate further superoxide production by competent cells. This results in a selfsustaining and longlasting process of clastogenesis, which may exceed the DNA repair system and ultimately lead to cancer. An increased cancer risk is indeed observed in conditions accompanied by CF formation. These include irradiated persons, asbestos workers, patients with chronic inflammatory diseases, HIV-infected persons, and the congenital breakage syndromes ataxia telangiectasia, Bloom's syndrome, and Fanconi's anemia. Because reactive oxygen species (ROS) are implicated in CF formation and CF action, antioxidants may be protective as anticlastogens and consequently as anticarcinogens. In persons at high risk because of their occupation, life style or place of residence, the presence of CF may represent an indication for chemoprevention of cancer by antioxidants. CF can be useful as biochemical markers and intermediate endpoints for the evaluation of promising drugs. They are therefore not only of interest as a mechanism by which ROS may exert genotoxic effects, but also have practical implications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300000     DOI: 10.1016/0891-5849(94)90246-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  46 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect.

Authors:  Xingmin Wang; Toby D Allen; Randal J May; Stanley Lightfoot; Courtney W Houchen; Mark M Huycke
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

Review 3.  Radiation-induced bystander signalling in cancer therapy.

Authors:  Kevin M Prise; Joe M O'Sullivan
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

4.  Radiation-induced bystander and adaptive responses in cell and tissue models.

Authors:  Kevin M Prise; Melvyn Folkard; Barry D Michael
Journal:  Dose Response       Date:  2006-09-23       Impact factor: 2.658

Review 5.  Clastogenic plasma factors: a short overview.

Authors:  Carita Lindholm; Anna Acheva; Sisko Salomaa
Journal:  Radiat Environ Biophys       Date:  2009-12-18       Impact factor: 1.925

6.  Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages.

Authors:  Xingmin Wang; Toby D Allen; Yonghong Yang; Danny R Moore; Mark M Huycke
Journal:  Cancer Prev Res (Phila)       Date:  2013-01-15

7.  Potential Adverse Public Health Effects Afforded by the Ingestion of Dietary Lipid Oxidation Product Toxins: Significance of Fried Food Sources.

Authors:  Martin Grootveld; Benita C Percival; Justine Leenders; Philippe B Wilson
Journal:  Nutrients       Date:  2020-04-01       Impact factor: 5.717

8.  Clastogenic factors as potential biomarkers of increased superoxide production.

Authors:  Ingrid Emerit
Journal:  Biomark Insights       Date:  2007-12-11

Review 9.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

10.  Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Authors:  Marie-Claude F Jaurand; Annie Renier; Julien Daubriac
Journal:  Part Fibre Toxicol       Date:  2009-06-12       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.